bpc 157 therapy orlando Peptide in Orlando, FL BPC-157 Peptide Therapy: Healing &

5A-1MQ-treated mice switched from WD to LD (WD/LD-T) showed a rather reduced relative abundance of Akkermansia compared to vehicle-treated DIO animals switched from WD to LD (WD/LD-V), suggesting a unique microbiome mechanism associated with weight loss in the vehicle-treated group switched from WD to LD compared to the 5A-1MQ-treated group that underwent the same diet switch

Saito A, Suzuki Y, Kitamura M, Ogata S, Yoshihara Y, Masuda S, et al

KLOW is the same three peptides plus a fourth, KPV

Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial